A Randomized, Open-Label, Two-way Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1306 Tablet and Co-administration of HGP0816 Tablet, HGP1404 Tablet in the Healthy Adults
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Ezetimibe (Primary) ; Ezetimibe/rosuvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 09 Aug 2017 Results published in the Clinical Therapeutics
- 24 Oct 2016 New trial record